These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11420091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
    Shen J, Benedict Gomes A, Gallagher A, Stafford K, Yoburn BC.
    Synapse; 2000 Dec 01; 38(3):322-7. PubMed ID: 11020235
    [Abstract] [Full Text] [Related]

  • 3. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC, Gomes BA, Rajashekara V, Patel C, Patel M.
    Synapse; 2003 Feb 01; 47(2):109-16. PubMed ID: 12454948
    [Abstract] [Full Text] [Related]

  • 4. Opioid receptor regulation in mice.
    Yoburn BC, Billings B, Duttaroy A.
    J Pharmacol Exp Ther; 1993 Apr 01; 265(1):314-20. PubMed ID: 8386239
    [Abstract] [Full Text] [Related]

  • 5. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M, Kumar P, Sunkaraneni S, Sirohi S, Walker EA, Yoburn BC.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):92-101. PubMed ID: 17349996
    [Abstract] [Full Text] [Related]

  • 6. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.
    Chan KW, Duttory A, Yoburn BC.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):225-8. PubMed ID: 9042594
    [Abstract] [Full Text] [Related]

  • 7. Mu-opioid receptor down-regulation and tolerance are not equally dependent upon G-protein signaling.
    Gomes BA, Shen J, Stafford K, Patel M, Yoburn BC.
    Pharmacol Biochem Behav; 2002 May 29; 72(1-2):273-8. PubMed ID: 11900797
    [Abstract] [Full Text] [Related]

  • 8. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
    Lee SC, Yoburn BC.
    Pharmacol Biochem Behav; 2000 Jun 29; 66(2):347-51. PubMed ID: 10880689
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo.
    Patel MB, Patel CN, Rajashekara V, Yoburn BC.
    Mol Pharmacol; 2002 Dec 29; 62(6):1464-70. PubMed ID: 12435815
    [Abstract] [Full Text] [Related]

  • 12. The effect of intrinsic efficacy on opioid tolerance.
    Duttaroy A, Yoburn BC.
    Anesthesiology; 1995 May 29; 82(5):1226-36. PubMed ID: 7741298
    [Abstract] [Full Text] [Related]

  • 13. The analgesic efficacy of fentanyl: relationship to tolerance and mu-opioid receptor regulation.
    Sirohi S, Dighe SV, Walker EA, Yoburn BC.
    Pharmacol Biochem Behav; 2008 Nov 29; 91(1):115-20. PubMed ID: 18640146
    [Abstract] [Full Text] [Related]

  • 14. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC, Purohit V, Patel K, Zhang Q.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):87-96. PubMed ID: 15363980
    [Abstract] [Full Text] [Related]

  • 15. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA, Navani DM, Yoburn BC.
    Pharmacol Biochem Behav; 2012 Mar 13; 101(1):155-65. PubMed ID: 22108651
    [Abstract] [Full Text] [Related]

  • 16. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
    Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Yajima Y, Suzuki T.
    Neuroscience; 2006 Mar 13; 138(2):609-19. PubMed ID: 16417975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.
    Sim-Selley LJ, Scoggins KL, Cassidy MP, Smith LA, Dewey WL, Smith FL, Selley DE.
    Br J Pharmacol; 2007 Aug 13; 151(8):1324-33. PubMed ID: 17572699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.